AP
BSX icon

Anchyra Partners’s Boston Scientific BSX Stock Holding History

Anchyra Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,379
Closed -$338K – 357
2026
Q1 		$338K Buy
5,379
+1,324
+33% +$106K 0.1% 193
2025
Q4 		$387K Buy
+4,055
New +$398K 0.12% 163

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Anchyra Partners's BSX Position: Q2 2026 in Review

Anchyra Partners sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 5,379 shares — an estimated $338K sold.

Anchyra Partners first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $387K in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Anchyra Partners reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Anchyra Partners sold 5,379 Boston Scientific shares in Q2 2026, an estimated $338K.
  • Anchyra Partners first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
  • Anchyra Partners's Boston Scientific position peaked at $387K in Q4 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.